D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Gladstone Investment Corp
GAIN
$648M
| $632K | ﹤0.01% |
51,671
+2,938
| +6% | +$33.8K |
|
3252
John B. Sanfilippo & Son
JBSS
$978M
| $632K | ﹤0.01% |
6,990
-1,792
| -20% | -$155K |
|
|
AMK
3253
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $632K | ﹤0.01% |
27,060
+3,672
| +16% | +$88.8K |
|
3254
SandRidge Energy
SD
$496M
| $631K | ﹤0.01% |
161,437
-146,475
| -48% | -$667K |
|
3255
BCE
BCE
$19.8B
| $629K | ﹤0.01% |
13,926
-268,950
| -95% | -$11.9M |
|
3256
Virtus Investment Partners
VRTS
$1.12B
| $628K | ﹤0.01% |
2,668
+1,052
| +65% | +$253K |
|
|
MAXN
3257
DELISTED
Maxeon Solar Technologies
MAXN
| $626K | ﹤0.01% |
198
-813
| -80% | -$3.1M |
|
3258
Nicolet Bankshares
NIC
$3.54B
| $625K | ﹤0.01% |
+7,493
| New | +$570K |
|
|
COLIU
3259
DELISTED
Colicity Inc. Units
COLIU
| $621K | ﹤0.01% |
+61,514
| New | +$628K |
|
|
HSKA
3260
DELISTED
Heska Corp
HSKA
| $620K | ﹤0.01% |
3,681
+524
| +17% | +$92.9K |
|
3261
PUT
Bath & Body Works
BBWI
$4.13B
| $619K | ﹤0.01% |
12,370
-281,418
| -96% | -$11.6M |
|
|
QADA
3262
DELISTED
QAD Inc.
QADA
| $619K | ﹤0.01% |
9,297
+876
| +10% | +$58.6K |
|
3263
BioCryst Pharmaceuticals
BCRX
$2.43B
| $618K | ﹤0.01% |
60,803
+17,163
| +39% | +$177K |
|
|
MTSC
3264
DELISTED
MTS Systems Corp
MTSC
| $618K | ﹤0.01% |
10,612
-34,370
| -76% | -$2.01M |
|
3265
CALL
Nabors Industries
NBR
$1.16B
| $617K | ﹤0.01% |
+6,600
| New | +$589K |
|
|
YALA
3266
Yalla Group
YALA
$809M
| $616K | ﹤0.01% |
24,624
-69,714
| -74% | -$1.69M |
|
3267
LPL Financial
LPLA
$26.5B
| $615K | ﹤0.01% |
4,328
-66,956
| -94% | -$8.54M |
|
3268
CALL
TripAdvisor
TRIP
$1.66B
| $613K | ﹤0.01% |
+11,400
| New | +$489K |
|
3269
PUT
Travel + Leisure Co
TNL
$4.68B
| $612K | ﹤0.01% |
+10,000
| New | +$543K |
|
|
MFA
3270
PUT
MFA Financial
MFA
$927M
| $611K | ﹤0.01% |
37,500
-15,000
| -29% | -$239K |
|
3271
Zymeworks
ZYME
$1.69B
| $611K | ﹤0.01% |
19,342
-48,944
| -72% | -$1.99M |
|
3272
American Outdoor Brands
AOUT
$158M
| $610K | ﹤0.01% |
24,200
-15,467
| -39% | -$332K |
|
3273
Farmers National Banc Corp
FMNB
$909M
| $609K | ﹤0.01% |
36,464
+21,946
| +151% | +$322K |
|
|
TACA
3274
DELISTED
Trepont Acquisition Corp I
TACA
| $608K | ﹤0.01% |
+62,001
| New | +$629K |
|
3275
Inogen
INGN
$171M
| $607K | ﹤0.01% |
11,559
-12,033
| -51% | -$601K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.